• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, April 22, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Solid-phase extraction of ibuprofen from pharmaceuticals

Bioengineer by Bioengineer
November 14, 2016
in Science News
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Dr. Michal Klivický et al., Bentham Science Publishers

The content of active ingredients in pharmaceuticals is mostly assessed by reversed-phase HPLC. Nevertheless, the excipients in case of suppositories are usually not soluble in commonly used mobile phases solvents (methanol, acetonitrile). That is the reason why a labour intensive and tedious sample pre-treatment is necessary, in order to remove the matrix from the sample.

The presence of Lewis acid sites on the surface of metal oxides is responsible for strong interactions with Lewis bases due to ligand exchange. Although this phenomenon is not desirable in chromatography, these interactions might be employed in a sample pre-treatment based on solid phase extraction.

We newly tested this approach on ibuprofen, which is a favourable drug for the management of pain and fever. Due to the inability of infants to swallow tablets, ibuprofen is often administered in the form of suppositories and oral suspensions in paediatric clinics.

Using the zirconium dioxide as the extraction material, efficient trapping of ibuprofen from a hydrophobic suppository matrix was enabled. It demonstrated the pivotal role of interactions between the carboxylic moiety of ibuprofen and the Lewis acid sites on the zirconia surface. The excellent extraction of ibuprofen was also obtained from the hydrophilic environment, which was tested on an oral suspension. Titania as a second tested material was not capable of trapping ibuprofen from pharmaceuticals efficiently due to its weaker ligand exchange properties.

We have described the first successful utilization of the ligand exchange process on zirconia in the extraction of ibuprofen from hydrophobic as well as hydrophilic media using two different dosages forms. The procedure can be applied in cases where excipients or a drug are not soluble in commonly used HPLC solvents and/or if co-eluting peaks from matrix are an issue. The recoveries of ibuprofen were 95 % and 94 % from suppositories and the oral suspension, respectively.

###

For more information about the article, please visit http://benthamscience.com/journals/current-analytical-chemistry/article/135981/

Reference: Klivický, M.; et al (2016). Solid-Phase Extraction of Ibuprofen from Pharmaceuticals via Ligand Exchange Using Zirconium Dioxide. Curr Anal Chem., DOI: 10.2174/1573411012666151022194146

Media Contact

Faizan ul Haq
[email protected]
@BenthamScienceP

http://benthamscience.com/

via scienmag.com

Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

MERS DNA vaccine induces immunity, protects from virus challenge in preclinical model

April 22, 2021
IMAGE

Little crop of horrors

April 22, 2021

Why the human body has not evolved to make childbirth easier — or has it?

April 22, 2021

Scientists uncover structure of light-driven enzyme with potential biofuel applications

April 22, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    A sturdier spike protein explains the faster spread of coronavirus variants

    45 shares
    Share 18 Tweet 11
  • UofL, Medtronic to develop epidural stimulation algorithms for spinal cord injury

    56 shares
    Share 22 Tweet 14
  • New evidence in search for the mysterious Denisovans

    34 shares
    Share 14 Tweet 9
  • Jonathan Wall receives $1.79 million to develop new amyloidosis treatment

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

VirologyZoology/Veterinary ScienceUniversity of WashingtonUrogenital SystemVirusUrbanizationWeather/StormsWeaponryViolence/CriminalsVehiclesVaccinesVaccine

Recent Posts

  • MERS DNA vaccine induces immunity, protects from virus challenge in preclinical model
  • Little crop of horrors
  • Why the human body has not evolved to make childbirth easier — or has it?
  • Scientists uncover structure of light-driven enzyme with potential biofuel applications
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In